Skip to content

Clinical trials

Observational Hematologic Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Observational Country / region: United States Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20042
20052
20071
20093
20111
20121
20132
20142
20162
20173
20191
20205
20211
20231
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting9
Enrolling by invitation5
Withdrawn3
Unknown status2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)4
American Thrombosis and Hemostasis Network2
Boston Children's Hospital2
St. Jude Children's Research Hospital2
Stanford University2
iSpecimen Inc2
Albert Einstein College of Medicine1
Ann & Robert H Lurie Children's Hospital of Chicago1
Bayer1
Beckman Coulter, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases40
Neoplasms8
Anemia7
Blood Coagulation Disorders5
Hemophilia A5
Hemostatic Disorders4
Neutropenia4
Anemia, Hemolytic3
Anemia, Sickle Cell3
Autoimmune Diseases3

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.